Neola Medical invites to presentation of the Q2 report 2026
Neola Medical AB (publ) invites investors, analysts and journalists to a live presentation of the Company’s Q2 report 2026 on Thursday, August 20, 2026, at 11:00 CEST. The presentation will be held online and hosted by Investor Studios. The Q2 report will be published earlier the same morning.
The report will be presented by CEO Hanna Sjöström and CFO David Folkesson. The presentation will be followed by a Q&A session, where viewers will have the opportunity to submit questions via the live chat.
Watch the presentation here:
https://youtube.com/live/r5ppKjIvrec?feature=share
The report and report presentation will be available at Neola Medical’s website:
https://neolamedical.com/neola-medical-investors/reports-and-financial-calendar/
For further questions after the presentation, contact CFO David Folkesson through below contact details.
For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com
David Folkesson, CFO
email: david.folkesson@neolamedical.com
About Neola Medical
Neola Medical AB (publ) develops an innovative medical technology device for non-invasive, continuous lung monitoring and real-time alerts of potentially life-threatening lung collapse in preterm born babies. By enabling instant detection, the technology aims to support earlier intervention, improve clinical decision-making, enhance long-term outcomes, and ultimately contribute to saving lives. The patented, cutting-edge technology was developed at Lund University in Sweden and is based on near-infrared light measurements in the lungs. Neola Medical builds on Sweden’s longstanding legacy of medical technology innovation and contributions to global health care. Neola Medical was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.